NYSE:STVNLife Sciences
Stevanato Group (NYSE:STVN) Margin Uptick Tests Bullish Earnings Narrative After Q1 2026 Results
Stevanato Group (NYSE:STVN) opened 2026 with Q1 revenue of €273.6 million and basic EPS of €0.10, alongside trailing 12 month revenue of about €1.2 billion and EPS of €0.52 that frame the latest quarter against a fuller earnings backdrop. Over recent periods, revenue has ranged from €256.6 million in Q1 2025 to €346.5 million in Q4 2025, while basic EPS has moved between €0.10 and €0.17 across those quarters, giving investors a clear view of how the top and bottom lines are tracking into the...